Literature DB >> 12489309

Dependency, impulsivity, and self-harm: traits hypothesized to underlie the association between cluster B personality and substance use disorders.

Alex Casillas1, Lee Anna Clark.   

Abstract

Cluster B personality disorders (PDs) (i.e., antisocial, borderline, histrionic, and narcissistic) typically show a high degree of comorbidity with substance use disorders (SUDs). Previous research suggests that the broad-based personality domains of Disinhibition and Negative Temperament/Neuroticism may be common factors to both types of disorders. Using a two-phase process (i.e., screening and follow-up), this study examined three lower-order personality traits (i.e., dependency, impulsivity, and self-harm) that fall within the Disinhibition and Neuroticism domains. The study evaluated the hypotheses that these traits (a) are related both to cluster B PDs and to SUDs; and (b) underlie the association between the two types of disorders. Results indicate that impulsivity and self-harm play a significant role in cluster B PDs and SUDs, as well as in their association with each other. However, dependency was not associated with either type of disorder. These results indicate that sets of individual traits can be of significant utility in understanding the comorbidity between PDs and SUDs.

Entities:  

Mesh:

Year:  2002        PMID: 12489309     DOI: 10.1521/pedi.16.5.424.22124

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  17 in total

1.  Emotional conditions disrupt behavioral control among individuals with dysregulated personality traits.

Authors:  Jenessa Sprague; Edelyn Verona
Journal:  J Abnorm Psychol       Date:  2010-05

2.  Personality disorders in early adolescence and the development of later substance use disorders in the general population.

Authors:  Patricia Cohen; Henian Chen; Thomas N Crawford; Judith S Brook; Kathy Gordon
Journal:  Drug Alcohol Depend       Date:  2007-01-16       Impact factor: 4.492

3.  Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum.

Authors:  Robert F Krueger; Kristian E Markon; Christopher J Patrick; Stephen D Benning; Mark D Kramer
Journal:  J Abnorm Psychol       Date:  2007-11

4.  Understanding the heterogeneity of BPD symptoms through latent class analysis: initial results and clinical correlates among inner-city substance users.

Authors:  Marina A Bornovalova; Roy Levy; Kim L Gratz; C W Lejuez
Journal:  Psychol Assess       Date:  2010-06

Review 5.  Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.

Authors:  Rama M Kamal; Martijn S van Noorden; Wim Wannet; Harmen Beurmanjer; Boukje A G Dijkstra; Arnt Schellekens
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

6.  Characteristics of individuals who make impulsive suicide attempts.

Authors:  Megan Spokas; Amy Wenzel; Gregory K Brown; Aaron T Beck
Journal:  J Affect Disord       Date:  2011-11-25       Impact factor: 4.839

7.  Commonalities and differences in characteristics of persons at risk for narcissism and mania.

Authors:  Daniel Fulford; Sheri L Johnson; Charles S Carver
Journal:  J Res Pers       Date:  2008-12

8.  Genetic and Environmental Associations Between Procrastination and Internalizing/Externalizing Psychopathology.

Authors:  Daniel E Gustavson; Alta du Pont; Alexander S Hatoum; Soo Hyun Rhee; William S Kremen; John K Hewitt; Naomi P Friedman
Journal:  Clin Psychol Sci       Date:  2017-06-11

9.  Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients.

Authors:  Declan T Barry; Mark Beitel; Brian Garnet; Dipa Joshi; Andrew Rosenblum; Richard S Schottenfeld
Journal:  J Clin Psychiatry       Date:  2009-07-14       Impact factor: 4.384

10.  The association between gambling pathology and personality disorders.

Authors:  Paul Sacco; Renee M Cunningham-Williams; Emily Ostmann; Edward L Spitznagel
Journal:  J Psychiatr Res       Date:  2008-03-04       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.